FDA/CDC
FDA/CDC
FDA authorizes convalescent plasma for COVID-19
The authorization allows the plasma to be distributed in the U.S. and administered by health care providers.
FDA/CDC
CDC data confirm mental health is suffering during COVID-19
The prevalence of symptoms of anxiety disorder alone was roughly three times that reported in the second quarter of 2019.
FDA/CDC
FDA okays new indication for esketamine nasal spray
“Esketamine may offer clinicians a new way to provide support to patients quickly in the midst of an urgent depressive episode,” said Dr. Gerard...
Latest News
One-third of outpatients with COVID-19 are unwell weeks later
“This should impact the perception of this being a mild illness in the young adult population and encourage them to comply with recommendations of...
FDA/CDC
FDA approves low-sodium treatment option for narcolepsy
Xywav is a novel oxybate product with 92% less sodium than Xyrem.
FDA/CDC
FDA okays emergency use for Impella RP in COVID-19 right heart failure
FDA/CDC
FDA okays first tau radiotracer to aid Alzheimer’s disease diagnosis
This is the first drug approved for imaging tau pathology, one of the two neuropathologic hallmarks of Alzheimer’s disease.
FDA/CDC
Remdesivir shortens COVID-19 time to recovery in published study
The NIAID reported initial promising results from the study earlier this month, which prompted the FDA to issue an emergency use authorization for...
News from the FDA/CDC
FDA tightens requirements for COVID-19 antibody tests
The U.S. Food and Drug Administration is tightening requirements for companies that develop COVID-19 antibody tests in an effort to combat fraud...
FDA/CDC
FDA authorizes emergency use of remdesivir for COVID-19
The designation means remdesivir can be distributed in the United States and administered intravenously by healthcare providers, as appropriate,...
FDA/CDC
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...